Introducing GPT-Rosalind for life sciences research

2026-03-25 · Source: OpenAI News · Field: Science & Research — Life Sciences & Biology, Health & Medical Research, Physical Sciences & Chemistry · Depth: Expert, medium

Summary

OpenAI has introduced GPT-Rosalind, a new frontier reasoning model specifically designed to accelerate scientific research and drug discovery in life sciences. Launched on April 16, 2026, this model series is optimized for complex scientific workflows, integrating enhanced tool use with a deeper understanding of chemistry, protein engineering, and genomics. GPT-Rosalind aims to expedite early-stage discovery by supporting evidence synthesis, hypothesis generation, and experimental planning, which are often time-intensive and fragmented tasks. It is available as a research preview in ChatGPT, Codex, and the API for qualified customers, and includes a freely accessible Life Sciences research plugin for Codex, enabling connection to over 50 scientific tools and data sources. Initial partners include Amgen, Moderna, and the Allen Institute, with evaluations showing leading performance on benchmarks like BixBench and LABBench2, and exceeding human expert performance in specific RNA sequence tasks.

Key takeaway

For AI Product Managers overseeing R&D in life sciences, GPT-Rosalind presents a significant opportunity to streamline discovery workflows. You should explore integrating this model and its associated plugin to enhance evidence synthesis, accelerate hypothesis generation, and improve experimental design, potentially reducing drug development timelines and increasing success rates. Request access to the research preview to evaluate its impact on your specific research challenges.

Key insights

GPT-Rosalind accelerates life sciences research by enhancing scientific reasoning and tool integration across complex workflows.

Principles

• AI can accelerate early-stage drug discovery.
• Domain-specific models improve scientific workflow efficiency.
• Tool integration is crucial for AI in scientific research.

Method

GPT-Rosalind supports multi-step research tasks like literature review, sequence-to-function interpretation, and experimental planning by reasoning over molecules, proteins, genes, and pathways, and by using scientific tools and databases.

In practice

• Use GPT-Rosalind for evidence synthesis and hypothesis generation.
• Integrate the Life Sciences research plugin with Codex for tool access.
• Apply the model for protein structure lookup and public dataset discovery.

Topics

• GPT-Rosalind
• Drug Discovery
• Scientific Workflows
• Protein Engineering
• Genomics

Code references

• openai/plugins

Best for: Executive, AI Product Manager, AI Scientist, Research Scientist, Director of AI/ML

Related on AIssential

• OpenAI debuts GPT-Rosalind, a new limited access model for life sciences, and broader Codex plugin on Github — GPT-Rosalind is a specialized AI model and ecosystem accelerating life sciences research through domain-specific reasoning and workflow integration.
• Introducing new capabilities to GPT-Rosalind — GPT-Rosalind integrates advanced AI with scientific workflows, significantly improving life sciences research efficiency and accuracy.
• OpenAI is giving away its life sciences AI model to help governments prepare for the next pandemic — OpenAI's GPT-Rosalind program provides specialized AI to accelerate biodefense research and pandemic preparedness for public benefit.
• OpenAI develops GPT-Rosalind for biology workflows — GPT-Rosalind specializes in biology workflows, addressing data complexity and interdisciplinary jargon for researchers.
• AI is reengineering drug discovery by speeding up testing and scanning petabytes of data for connections between diseases — AI significantly enhances drug discovery by analyzing vast data to predict targets, efficacy, and disease interrelationships, improving success rates.
• Enhancing success rates in therapeutic antibody design through generative models — DualGPT-AB is a dual-stage GPT framework optimizing therapeutic antibody design for specificity and developability.

Open in AIssential →

Editorial summary, takeaway, and curation by AIssential. Original article published by OpenAI News.